199 related articles for article (PubMed ID: 21792892)
21. WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis.
Zhou X; Ren Y; Liu A; Jin R; Jiang Q; Huang Y; Kong L; Wang X; Zhang L
Sci Rep; 2014 Dec; 4():7461. PubMed ID: 25514838
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation.
Daniel JM; Dutzmann J; Bielenberg W; Widmer-Teske R; Gündüz D; Hamm CW; Sedding DG
Basic Res Cardiol; 2012 May; 107(3):261. PubMed ID: 22418922
[TBL] [Abstract][Full Text] [Related]
23. Synergistic effect of metronomic dosing of cyclophosphamide combined with specific antitumor immunotherapy in a murine melanoma model.
Hermans IF; Chong TW; Palmowski MJ; Harris AL; Cerundolo V
Cancer Res; 2003 Dec; 63(23):8408-13. PubMed ID: 14679003
[TBL] [Abstract][Full Text] [Related]
24. CCR5 Blockade Suppresses Melanoma Development Through Inhibition of IL-6-Stat3 Pathway via Upregulation of SOCS3.
Tang Q; Jiang J; Liu J
Inflammation; 2015 Dec; 38(6):2049-56. PubMed ID: 26047948
[TBL] [Abstract][Full Text] [Related]
25. Synergistic antitumor effects of CpG oligodeoxynucleotide and STAT3 inhibitory agent JSI-124 in a mouse melanoma tumor model.
Molavi O; Ma Z; Hamdy S; Lai R; Lavasanifar A; Samuel J
Immunol Cell Biol; 2008; 86(6):506-14. PubMed ID: 18392040
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic suppression of constitutive and inducible JAK\STAT activation in head and neck squamous cell carcinoma.
Kupferman ME; Jayakumar A; Zhou G; Xie T; Dakak-Yazici Y; Zhao M; Ju J; Mandal M; Jasser S; Madden T; Myers JN; Priebe W
J Exp Ther Oncol; 2009; 8(2):117-27. PubMed ID: 20192118
[TBL] [Abstract][Full Text] [Related]
27. STAT3 inhibition by WP1066 suppresses the growth and invasiveness of bladder cancer cells.
Tsujita Y; Horiguchi A; Tasaki S; Isono M; Asano T; Ito K; Asano T; Mayumi Y; Kushibiki T
Oncol Rep; 2017 Oct; 38(4):2197-2204. PubMed ID: 28849140
[TBL] [Abstract][Full Text] [Related]
28. Low Dose Cyclophosphamide Modulates Tumor Microenvironment by TGF-β Signaling Pathway.
Zhong H; Lai Y; Zhang R; Daoud A; Feng Q; Zhou J; Shang J
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023984
[TBL] [Abstract][Full Text] [Related]
29. [Study of Kinase Inhibitor WP1066 on the STAT3/JAK2 of Prostate Stromal Cells].
Li YX; Li JM; Wei Q; Zhang ZP; Wu J; Wang AG
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):65-68. PubMed ID: 29737092
[TBL] [Abstract][Full Text] [Related]
30. A two-herb formula inhibits STAT3 signaling and exerts anti-melanoma effects in cell and animal models.
Li JK; Chou JY; Yin CL; Fu XQ; Wu Y; Chen YJ; Bai JX; Wu JY; Liang C; Yu ZL
J Ethnopharmacol; 2021 Mar; 268():113671. PubMed ID: 33307054
[TBL] [Abstract][Full Text] [Related]
31. A TCM formula comprising Sophorae Flos and Lonicerae Japonicae Flos alters compositions of immune cells and molecules of the STAT3 pathway in melanoma microenvironment.
Liu YX; Bai JX; Li T; Fu XQ; Guo H; Zhu PL; Chan YC; Chou JY; Yin CL; Li JK; Wang YP; Chen YJ; Yu ZL
Pharmacol Res; 2019 Apr; 142():115-126. PubMed ID: 30797070
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma.
Li Y; Song Y; Li P; Li M; Wang H; Xu T; Yu X; Yu Y; Tai Y; Chen P; Cai X; Wang X; Xiang L; Deng R; Zhang X; Gao L; Wang X; Liu J; Cao F
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32152220
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of Stat3 in melanoma: reprogramming the immune microenvironment as an anticancer therapeutic strategy.
Emeagi PU; Maenhout S; Dang N; Heirman C; Thielemans K; Breckpot K
Gene Ther; 2013 Nov; 20(11):1085-92. PubMed ID: 23804077
[TBL] [Abstract][Full Text] [Related]
34. Dihydroartemisinin inhibits melanoma by regulating CTL/Treg anti-tumor immunity and STAT3-mediated apoptosis via IL-10 dependent manner.
Yu R; Jin L; Li F; Fujimoto M; Wei Q; Lin Z; Ren X; Jin Q; Li H; Meng F; Jin G
J Dermatol Sci; 2020 Sep; 99(3):193-202. PubMed ID: 32859456
[TBL] [Abstract][Full Text] [Related]
35. Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma.
de Groot J; Liang J; Kong LY; Wei J; Piao Y; Fuller G; Qiao W; Heimberger AB
Oncotarget; 2012 Sep; 3(9):1036-48. PubMed ID: 23013619
[TBL] [Abstract][Full Text] [Related]
36. [Signal transducers and activators of transcription-3 modulates human squamous cell carcinoma invasion via targeting mircoRNA-21 in vitro].
Liu AQ; Li SS; Zhou X; Wang XD; Zhang L
Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Sep; 48(9):539-44. PubMed ID: 24314280
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways.
Wang Y; Chen L; Bao Z; Li S; You G; Yan W; Shi Z; Liu Y; Yang P; Zhang W; Han L; Kang C; Jiang T
Oncol Rep; 2011 Nov; 26(5):1173-80. PubMed ID: 21887474
[TBL] [Abstract][Full Text] [Related]
38. Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells of Melanoma.
Huang L; Xu Y; Fang J; Liu W; Chen J; Liu Z; Xu Q
Front Immunol; 2021; 12():654749. PubMed ID: 33936081
[TBL] [Abstract][Full Text] [Related]
39. Induction of Bv8 expression by granulocyte colony-stimulating factor in CD11b+Gr1+ cells: key role of Stat3 signaling.
Qu X; Zhuang G; Yu L; Meng G; Ferrara N
J Biol Chem; 2012 Jun; 287(23):19574-84. PubMed ID: 22528488
[TBL] [Abstract][Full Text] [Related]
40. Combination of 4-hydroperoxy cyclophosphamide and methotrexate inhibits IL-6/sIL-6R-induced RANKL expression in fibroblast-like synoviocytes via suppression of the JAK2/STAT3 and p38MAPK signaling pathway.
Niu HQ; Zhao WP; Zhao XC; Luo J; Qin KL; Chen KL; Li XF
Int Immunopharmacol; 2018 Aug; 61():45-53. PubMed ID: 29803913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
